Serum antibody decay in adults following natural respiratory syncytial virus infection
- 22 September 2006
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 78 (11) , 1493-1497
- https://doi.org/10.1002/jmv.20724
Abstract
Serum antibody decay following RSV infection in adults was examined to evaluate the durability of the immune response. Twenty subjects with RSV infection and 10 subjects who remained RSV uninfected had blood samples obtained over 16–25 months analyzed by microneutralization assay and enzyme immunoassay. The mean titers of infected subjects rose approximately eightfold post-infection. The mean rate of antibody decline was −0.20 log 2 titer per month which led to a ≥fourfold drop in titer in 75% of subjects at 1 year. In contrast, titers of uninfected subjects were relatively stable. The partial immunity resulting from a boost in serum antibody following natural RSV infection in adults appears to be short lived. J. Med. Virol. 78:1493–1497, 2006.Keywords
This publication has 16 references indexed in Scilit:
- Aging, Immunity, and the Varicella–Zoster VirusNew England Journal of Medicine, 2005
- Respiratory Syncytial Virus Infection in Elderly and High-Risk AdultsNew England Journal of Medicine, 2005
- Experimental infection of humans with A2 respiratory syncytial virusPublished by Elsevier ,2004
- Mortality Associated With Influenza and Respiratory Syncytial Virus in the United StatesJAMA, 2003
- Legionella Pneumophila Serogroup 1 Antibody Kinetics in Patients with Legionnaires' Disease: Implications for Serological DiagnosisScandinavian Journal of Infectious Diseases, 2003
- Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk InfantsPediatrics, 1998
- Measles Vaccine Effectiveness and Duration of Vaccine-induced Immunity in the Absence of Boosting from Exposure to Measles VirusThe Pediatric Infectious Disease Journal, 1996
- Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60Vaccine, 1996
- Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody levelThe Journal of Pediatrics, 1981
- Influenza subunit vaccine: antibody responses to one and two doses of vaccine and length of response, with particular reference to the elderly.BMJ, 1977